Triple-Hormone Synergy for Advanced Weight Management Research

🔬 Product Overview

Retatrutide is a cutting-edge triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This multifaceted mechanism offers unparalleled potential in weight loss and metabolic health research. The 20mg vial provides a more cost-effective option for extended research protocols.

🚀 Key Benefits

• Triple Hormone Activation: Engages GLP-1, GIP, and glucagon receptors to synergistically enhance weight loss and metabolic regulation.
• Superior Weight Reduction: Clinical studies have demonstrated up to 24.2% body weight loss over 48 weeks with 12 mg dosing, surpassing results from other treatments like Ozempic and Mounjaro.
• Enhanced Metabolic Health: Demonstrated improvements in liver fat content and cardiometabolic markers, indicating broader health benefits.
• Cost Efficiency: Purchasing the 20mg vial reduces the cost per milligram compared to the 10mg option, offering better value for extended research needs.

🧪 Composition

• Active Ingredient: Retatrutide
• Concentration: 20mg per vial
• Form: Lyophilized peptide powder

📦 Usage & Storage

• Intended Use: For research purposes only
• Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.

🛒 Order your 20mg Retatrutide today for £350